Pulmonary Hypertension: A Contemporary Review
Open accessThe DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Abstract
Major advances in pulmonary arterial hypertension, pulmonary hypertension (PH) associated with lung disease, and chronic thromboembolic PH cast new light on the pathogenetic mechanisms, epidemiology, diagnostic approach, and therapeutic armamentarium for pulmonary vascular disease. Here, we summarize key basic, translational, and clinical PH reports, emphasizing findings that build on current state-of-the-art research. This review includes cutting-edge progress in translational pulmonary vascular biology, with a guide to the diagnosis of patients in clinical practice, incorporating recent PH definition revisions that continue emphasis on early detection of disease. PH management is reviewed including an overview of the evolving considerations for the approach to treatment of PH in patients with cardiopulmonary comorbidities, as well as a discussion of the groundbreaking sotatercept data for the treatment of pulmonary arterial hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Empagliflozin in heart failure with a preserved ejection fraction
Anker, S. D., Butler, J., Filippatos, G., Ferreira, J. P., Bocchi, E., Böhm, M., Brunner–La Rocca, H.-P., Choi, D.-J., Chopra, V., Chuquiure-Valenzuela, E., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107038 · Cited by 4,874
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac237 · Cited by 3,975
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.01913-2018 · Cited by 3,813
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00879-2022 · Cited by 2,247
Ford, I., & Norrie, J. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510059 · Cited by 1,405
Chronic thromboembolic pulmonary hypertension
Kim, N. H., Delcroix, M., Jais, X., Madani, M. M., Matsubara, H., Mayer, E., Ogo, T., Tapson, V. F., Ghofrani, H.-A., & Jenkins, D. P. (2019) · European Respiratory Journal · doi:10.1183/13993003.01915-2018 · Cited by 1,007
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
Hoeper, M. M., Badesch, D. B., Ghofrani, H. A., Gibbs, J. S. R., Gomberg-Maitland, M., McLaughlin, V. V., Preston, I. R., Souza, R., Waxman, A. B., Grünig, E., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2213558 · Cited by 728
Hoeper, M. M., Kramer, T., Pan, Z., Eichstaedt, C. A., Spiesshoefer, J., Benjamin, N., Olsson, K. M., Meyer, K., Vizza, C. D., Vonk-Noordegraaf, A., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00740-2017 · Cited by 660
Predicting Survival in Patients With Pulmonary Arterial Hypertension
Benza, R. L., Gomberg-Maitland, M., Elliott, C. G., Farber, H. W., Foreman, A. J., Frost, A. E., McGoon, M. D., Pasta, D. J., Selej, M., Burger, C. D., et al. (2019) · Chest · doi:10.1016/j.chest.2019.02.004 · Cited by 643
Sotatercept for the Treatment of Pulmonary Arterial Hypertension
Humbert, M., McLaughlin, V., Gibbs, J. S. R., Gomberg-Maitland, M., Hoeper, M. M., Preston, I. R., Souza, R., Waxman, A., Escribano Subias, P., Feldman, J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2024277 · Cited by 608
Benza, R. L., Gomberg-Maitland, M., Miller, D. P., Frost, A., Frantz, R. P., Foreman, A. J., Badesch, D. B., & McGoon, M. D. (2012) · Chest · doi:10.1378/chest.11-0676 · Cited by 557
Guazzi, M., Vicenzi, M., Arena, R., & Guazzi, M. D. (2011) · Circulation · doi:10.1161/circulationaha.110.983866 · Cited by 545
Lewis, G. D., Shah, R., Shahzad, K., Camuso, J. M., Pappagianopoulos, P. P., Hung, J., Tawakol, A., Gerszten, R. E., Systrom, D. M., Bloch, K. D., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.716373 · Cited by 515
The pathophysiology of chronic thromboembolic pulmonary hypertension
Simonneau, G., Torbicki, A., Dorfmüller, P., & Kim, N. (2017) · European Respiratory Review · doi:10.1183/16000617.0112-2016 · Cited by 461
Morrell, N. W., Yang, X., Upton, P. D., Jourdan, K. B., Morgan, N., Sheares, K. K., & Trembath, R. C. (2001) · Circulation · doi:10.1161/hc3201.094152 · Cited by 453
Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension
Bertero, T., Oldham, W. M., Cottrill, K. A., Pisano, S., Vanderpool, R. R., Yu, Q., Zhao, J., Tai, Y., Tang, Y., Zhang, Y.-Y., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86387 · Cited by 439
Mahapatra, S., Nishimura, R. A., Sorajja, P., Cha, S., & McGoon, M. D. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.054 · Cited by 416
Maron, B. A., Hess, E., Maddox, T. M., Opotowsky, A. R., Tedford, R. J., Lahm, T., Joynt, K. E., Kass, D. J., Stephens, T., Stanislawski, M. A., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.020207 · Cited by 403
Self-citationIdentification of rare sequence variation underlying heritable pulmonary arterial hypertension
Gräf, S., Haimel, M., Bleda, M., Hadinnapola, C., Southgate, L., Li, W., Hodgson, J., Liu, B., Salmon, R. M., Southwood, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03672-4 · Cited by 380
Humbert, M., Yaici, A., de Groote, P., Montani, D., Sitbon, O., Launay, D., Gressin, V., Guillevin, L., Clerson, P., Simonneau, G., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30541 · Cited by 379
Fayyaz, A. U., Edwards, W. D., Maleszewski, J. J., Konik, E. A., DuBrock, H. M., Borlaug, B. A., Frantz, R. P., Jenkins, S. M., & Redfield, M. M. (2018) · Circulation · doi:10.1161/circulationaha.117.031608 · Cited by 351
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension
Hoeper, M. M., Pausch, C., Olsson, K. M., Huscher, D., Pittrow, D., Grünig, E., Staehler, G., Vizza, C. D., Gall, H., Distler, O., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.02311-2021 · Cited by 349
Hoendermis, E. S., Liu, L. C. Y., Hummel, Y. M., van der Meer, P., de Boer, R. A., Berger, R. M. F., van Veldhuisen, D. J., & Voors, A. A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv336 · Cited by 324
Miller, W. L., Grill, D. E., & Borlaug, B. A. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2013.05.001 · Cited by 318
Michelakis, E. D., Gurtu, V., Webster, L., Barnes, G., Watson, G., Howard, L., Cupitt, J., Paterson, I., Thompson, R. B., Chow, K., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aao4583 · Cited by 316
Maron, B. A., Brittain, E. L., Hess, E., Waldo, S. W., Barón, A. E., Huang, S., Goldstein, R. H., Assad, T. R., Wertheim, B. M., Alba, G. A., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30317-9 · Cited by 312
Self-citationAn official European Respiratory Society statement: pulmonary haemodynamics during exercise
Kovacs, G., Herve, P., Barbera, J. A., Chaouat, A., Chemla, D., Condliffe, R., Garcia, G., Grünig, E., Howard, L., Humbert, M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00578-2017 · Cited by 307
Nassif, M. E., Qintar, M., Windsor, S. L., Jermyn, R., Shavelle, D. M., Tang, F., Lamba, S., Bhatt, K., Brush, J., Civitello, A., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.052503 · Cited by 281
Houston, B. A., Brittain, E. L., & Tedford, R. J. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2207410 · Cited by 280
Role for DNA Damage Signaling in Pulmonary Arterial Hypertension
Meloche, J., Pflieger, A., Vaillancourt, M., Paulin, R., Potus, F., Zervopoulos, S., Graydon, C., Courboulin, A., Breuils-Bonnet, S., Tremblay, È., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.006167 · Cited by 254
ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension
Yung, L.-M., Yang, P., Joshi, S., Augur, Z. M., Kim, S. S. J., Bocobo, G. A., Dinter, T., Troncone, L., Chen, P.-S., McNeil, M. E., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz5660 · Cited by 248
Jaïs, X., Brenot, P., Bouvaist, H., Jevnikar, M., Canuet, M., Chabanne, C., Chaouat, A., Cottin, V., De Groote, P., Favrolt, N., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00214-4 · Cited by 237
Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis
Lajoie, A. C., Lauzière, G., Lega, J.-C., Lacasse, Y., Martin, S., Simard, S., Bonnet, S., & Provencher, S. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00027-8 · Cited by 235
Vanderpool, R. R., Saul, M., Nouraie, M., Gladwin, M. T., & Simon, M. A. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.0128 · Cited by 227
The Critical Role of Pulmonary Arterial Compliance in Pulmonary Hypertension
Thenappan, T., Prins, K. W., Pritzker, M. R., Scandurra, J., Volmers, K., & Weir, E. K. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201509-599fr · Cited by 223
Revised Definition of Pulmonary Hypertension and Approach to Management: A Clinical Primer
Maron, B. A. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.029024 · Cited by 213
Self-citationRhodes, C. J., Batai, K., Bleda, M., Haimel, M., Southgate, L., Germain, M., Pauciulo, M. W., Hadinnapola, C., Aman, J., Girerd, B., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30409-0 · Cited by 210
Boucly, A., Weatherald, J., Savale, L., de Groote, P., Cottin, V., Prévot, G., Chaouat, A., Picard, F., Horeau-Langlard, D., Bourdin, A., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.02419-2021 · Cited by 207
Macitentan in pulmonary hypertension due to left ventricular dysfunction
Vachiéry, J.-L., Delcroix, M., Al-Hiti, H., Efficace, M., Hutyra, M., Lack, G., Papadakis, K., & Rubin, L. J. (2018) · European Respiratory Journal · doi:10.1183/13993003.01886-2017 · Cited by 207
Boucly, A., Savale, L., Jaïs, X., Bauer, F., Bergot, E., Bertoletti, L., Beurnier, A., Bourdin, A., Bouvaist, H., Bulifon, S., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3698oc · Cited by 204
Maron, B. A., Zhang, Y.-Y., White, K., Chan, S. Y., Handy, D. E., Mahoney, C. E., Loscalzo, J., & Leopold, J. A. (2012) · Circulation · doi:10.1161/circulationaha.112.094722 · Cited by 200
Self-citationAdaptive design clinical trials: a review of the literature and ClinicalTrials.gov
Bothwell, L. E., Avorn, J., Khan, N. F., & Kesselheim, A. S. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-018320 · Cited by 196
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis
Hoeper, M. M., Dwivedi, K., Pausch, C., Lewis, R. A., Olsson, K. M., Huscher, D., Pittrow, D., Grünig, E., Staehler, G., Vizza, C. D., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00097-2 · Cited by 191
Valerio, C. J., Schreiber, B. E., Handler, C. E., Denton, C. P., & Coghlan, J. G. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37838 · Cited by 183
Soluble Guanylate Cyclase Stimulators and Activators
Sandner, P., Zimmer, D. P., Milne, G. T., Follmann, M., Hobbs, A., & Stasch, J.-P. (2018) · Handbook of Experimental Pharmacology · doi:10.1007/164_2018_197 · Cited by 180
The Influence of Age on Hemodynamic Parameters During Rest and Exercise in Healthy Individuals
Wolsk, E., Bakkestrøm, R., Thomsen, J. H., Balling, L., Andersen, M. J., Dahl, J. S., Hassager, C., Møller, J. E., & Gustafsson, F. (2017) · JACC: Heart Failure · doi:10.1016/j.jchf.2016.10.012 · Cited by 177
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension
Humbert, M. J. C., McLaughlin, V. V., Gibbs, J. S. R., Gomberg‐Maitland, M., Hoeper, M. M., Preston, I. R., Souza, R., Waxman, A. B., Ghofrani, H. A., Subías, P. E., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01347-2022 · Cited by 176
Hemnes, A. R., Beck, G. J., Newman, J. H., Abidov, A., Aldred, M. A., Barnard, J., Berman Rosenzweig, E., Borlaug, B. A., Chung, W. K., Comhair, S. A. A., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.311737 · Cited by 174
Self-citationThree- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension
Chin, K. M., Sitbon, O., Doelberg, M., Feldman, J., Gibbs, J. S. R., Grünig, E., Hoeper, M. M., Martin, N., Mathai, S. C., McLaughlin, V. V., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.07.057 · Cited by 171
Current and future treatments of pulmonary arterial hypertension
Sommer, N., Ghofrani, H. A., Pak, O., Bonnet, S., Provencher, S., Sitbon, O., Rosenkranz, S., Hoeper, M. M., & Kiely, D. G. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15016 · Cited by 166
Self-citationExercise Pulmonary Hypertension Predicts Clinical Outcomes in Patients With Dyspnea on Effort
Ho, J. E., Zern, E. K., Lau, E. S., Wooster, L., Bailey, C. S., Cunningham, T., Eisman, A. S., Hardin, K. M., Farrell, R., Sbarbaro, J. A., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.10.048 · Cited by 165
Botney, M. D., Bahadori, L. M., & Gold, L. I. (1994) · PubMed · Cited by 162
Brener, M. I., Masoumi, A., Ng, V. G., Tello, K., Bastos, M. B., Cornwell, W. K., Hsu, S., Tedford, R. J., Lurz, P. C., Rommel, K., et al. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.009101 · Cited by 162
Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension
Assad, T. R., Maron, B. A., Robbins, I. M., Xu, M., Huang, S., Harrell, F. E., Farber-Eger, E. H., Wells, Q. S., Choudhary, G., Hemnes, A. R., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.3882 · Cited by 160
Self-citationKolte, D. S., Lakshmanan, S., Jankowich, M. D., Brittain, E. L., Maron, B. A., & Choudhary, G. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009729 · Cited by 159
Self-citationGrünig, E., MacKenzie, A., Peacock, A. J., Eichstaedt, C. A., Benjamin, N., Nechwatal, R., Ulrich, S., Saxer, S., Bussotti, M., Sommaruga, M., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa696 · Cited by 159
Mechano-induced cell metabolism promotes microtubule glutamylation to force metastasis
Torrino, S., Grasset, E. M., Audebert, S., Belhadj, I., Lacoux, C., Haynes, M., Pisano, S., Abélanet, S., Brau, F., Chan, S. Y., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.05.009 · Cited by 150
Kawakami, T., Matsubara, H., Shinke, T., Abe, K., Kohsaka, S., Hosokawa, K., Taniguchi, Y., Shimokawahara, H., Yamada, Y., Kataoka, M., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00171-0 · Cited by 142
Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure
Maron, B. A., Kovács, G., Vaidya, A., Bhatt, D. L., Nishimura, R. A., Mak, S. S., Guazzi, M., & Tedford, R. J. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.10.007 · Cited by 142
Self-citationPulmonary Hypertension in Patients With COPD
Vizza, C. D., Hoeper, M. M., Huscher, D., Pittrow, D., Benjamin, N., Olsson, K. M., Ghofrani, H. A., Held, M., Klose, H. F. E., Lange, T. J., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.02.012 · Cited by 141
Threshold of Pulmonary Hypertension Associated With Increased Mortality
Strange, G. A., Stewart, S., Celermajer, D. S., Prior, D., Scalia, G. M., Marwick, T. H., Gabbay, E., Ilton, M. K., Joseph, M. X., Codde, J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.482 · Cited by 138
NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension
Samokhin, A. O., Stephens, T., Wertheim, B. M., Wang, R., Vargas, S. O., Yung, L., Cao, M., Brown, M. G., Arons, E., Dieffenbach, P. B., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aap7294 · Cited by 135
Self-citationPotus, F., Pauciulo, M. W., Cook, E. K., Zhu, N., Hsieh, A., Welch, C. L., Shen, Y., Tian, L., Lima, P., Mewburn, J. D., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044320 · Cited by 133
Huston, J., Maron, B. A., French, J. K., Huang, S., Thayer, T. E., Farber‐Eger, E. H., Wells, Q. S., Choudhary, G., Hemnes, A. R., & Brittain, E. L. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.3345 · Cited by 130
Self-citationOlsson, K. M., Hoeper, M. M., Pausch, C., Grünig, E., Huscher, D., Pittrow, D., Rosenkranz, S., & Gall, H. J. (2021) · European Respiratory Journal · doi:10.1183/13993003.01483-2021 · Cited by 129
Screening for pulmonary arterial hypertension in adults carrying aBMPR2mutation
Montani, D., Girerd, B., Jaïs, X., Laveneziana, P., Lau, E., Bouchachi, A., Hascoët, S., Günther, S., Godinas, L., Parent, F., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.04229-2020 · Cited by 125
Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension
Hodgson, J., Swietlik, E. M., Salmon, R. M., Hadinnapola, C., Nikolić, I., Wharton, J., Guo, J., Liley, J., Haimel, M., Bleda, M., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201906-1141oc · Cited by 123
Zeder, K., Banfi, C., Steinrisser-Allex, G., Maron, B. A., Humbert, M. J. C., Lewis, G. D., Berghold, A., Olschewski, H., & Kovács, G. (2022) · European Respiratory Journal · doi:10.1183/13993003.03181-2021 · Cited by 123
Self-citationElevated pulmonary vascular resistance predicts mortality in COPD patients
Zeder, K., Avian, A., Bachmaier, G., Douschan, P., Foris, V., Sassmann, T., Troester, N., Brčić, L., Fuchsjäger, M., Marsh, L. M., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.00944-2021 · Cited by 122
Self-citationPulmonary hypertension in chronic interstitial lung diseases
Caminati, A., Cassandro, R., & Harari, S. A. (2013) · European Respiratory Review · doi:10.1183/09059180.00002713 · Cited by 121
Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension
Nikolić, I., Yung, L., Yang, P. B., Malhotra, R. K., Paskin-Flerlage, S. D., Dinter, T., Bocobo, G. A., Tumelty, K. E., Faugno, A. J., Troncone, L., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1236oc · Cited by 119
Hong, J. S., Arneson, D. V., Umar, S., Ruffenach, G., Cunningham, C. M., Ahn, I. S., Diamante, G., Bhetraratana, M., Park, J. F., Said, E., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202006-2169oc · Cited by 116
Hemnes, A. R., Leopold, J. A., Radeva, M., Beck, G. J., Abidov, A. A., Aldred, M. A., Barnard, J., Rosenzweig, E. B., Borlaug, B. A., Chung, W. K., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.05.038 · Cited by 115
Self-citationXanthouli, P., Jordan, S., Milde, N., Marra, A. M., Blank, N., Egenlauf, B., Gorenflo, M., Harutyunova, S., Lorenz, H., Nagel, C., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216476 · Cited by 112
Obesity Is Associated With Pulmonary Hypertension and Modifies Outcomes
Frank, R. C., Min, J., Abdelghany, M., Paniagua, S. M., Bhattacharya, R., Bhambhani, V., Pomerantsev, E. V., & Ho, J. E. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014195 · Cited by 108
Aldosterone Receptor Antagonists: Effective but Often Forgotten
Maron, B. A., & Leopold, J. A. (2010) · Circulation · doi:10.1161/circulationaha.109.895235 · Cited by 103
Self-citationLewis, R. A., Thompson, A. A. R., Billings, C., Charalampopoulos, A. F., Elliot, C. A., Hamilton, N., Hill, C., Hurdman, J. A., Rajaram, S., Sabroe, I., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00041-2020 · Cited by 96
Mesenchymal Stem Cell Extracellular Vesicles Reverse Sugen/Hypoxia Pulmonary Hypertension in Rats
Klinger, J. R., Pereira, M. G., Tatto, M. D., Brodsky, A. S., Wu, K. Q., Dooner, M. S., Borgovan, T., Wen, S., Goldberg, L. R., Aliotta, J. M., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0154oc · Cited by 95
Self-citationTwist1 in Hypoxia-induced Pulmonary Hypertension through Transforming Growth Factor-β–Smad Signaling
Mammoto, T., Muyleart, M., Konduri, G. G., & Mammoto, A. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0323oc · Cited by 94
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension
Badagliacca, R., D’Alto, M., Ghio, S., Argiento, P., Bellomo, V., Brunetti, N. D., Casu, G., Confalonieri, M., Corda, M., Correale, M., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202004-1006oc · Cited by 88
Targeting Jak–Stat Signaling in Experimental Pulmonary Hypertension
Yerabolu, D., Weiß, A., Kojonazarov, B. K., Boehm, M., Schlueter, B. C., Ruppert, C., Günther, A., Jonigk, D. D., Grimminger, F., Ghofrani, H. A., et al. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0431oc · Cited by 88
Zehendner, C. M., Valasarajan, C., Werner, A., Boeckel, J., Bischoff, F. C., John, D., Weirick, T., Glaser, S.-F., Roßbach, O., Jaé, N., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201910-2041oc · Cited by 87
PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension
Hennigs, J. K., Cao, A., Li, C. G., Shi, M., Mienert, J., Miyagawa, K., Körbelin, J., Marciano, D. P., Chen, P.-I., Roughley, M., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.316339 · Cited by 84
Prins, K. W., Duval, S., Markowitz, J., PRITZKER, M. R., & Thenappan, T. (2016) · Pulmonary Circulation · doi:10.1086/690017 · Cited by 80
Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension
Galkin, A., Sitapara, R. A., Clemons, B., Garcia, E., Kennedy, M., Guimond, D. M., Carter, L., Douthitt, A. J., Osterhout, R. E., Gandjeva, A., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.02356-2021 · Cited by 80
Guignabert, C., Savale, L., Boucly, A., Thuillet, R., Tu, L., Ottaviani, M., Rhodes, C. J., de Groote, P., Prévôt, G., Bergot, E., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.061501 · Cited by 80
Wang, L., Rice, M., Swist, S., Kubin, T., Wu, F., Wang, S., Kraut, S., Weißmann, N., Böttger, T., Wheeler, M., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047375 · Cited by 78
Subcellular Localization of Oxidants and Redox Modulation of Endothelial Nitric Oxide Synthase
Maron, B. A., & Michel, T. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-1207 · Cited by 76
Self-citationRahaghi, F. N., Nardelli, P., Harder, E. M., Singh, I., Vegas‐Sánchez‐Ferrero, G., Ross, J. C., Estépar, R. S. J., Ash, S. Y., Hunsaker, A. R., Maron, B. A., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.06.069 · Cited by 75
Self-citationThe evolving landscape of pulmonary arterial hypertension clinical trials
Weatherald, J. C., Boucly, A., Peters, A. E., Montani, D., Prasad, K., Psotka, M. A., Zannad, F. M., Gomberg‐Maitland, M., McLaughlin, V. V., Simonneau, G., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01601-4 · Cited by 73
Gall, H. J., Yogeswaran, A., Fuge, J., Sommer, N., Grimminger, F., Seeger, W., Olsson, K. M., Hoeper, M. M., Richter, M. J., Tello, K., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100822 · Cited by 72
Self-citationChelladurai, P., Kuenne, C. T., Bourgeois, A., Günther, S., Valasarajan, C., Cherian, A. V., Rottier, R. J., Romanet, C., Weigert, A., Boucherat, O., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abe5407 · Cited by 71
Kolaitis, N. A., Zamanian, R. T., Pérez, V. D. J., Badesch, D. B., Benza, R. L., Burger, C. D., Chakinala, M. M., Elwing, J., Feldman, J., Lammi, M. R., et al. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202007-774oc · Cited by 69
SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension
Veith, C., Vartürk-Özcan, I., Wujak, M., Hadžić, S., Wu, C., Knoepp, F., Kraut, S., Petrovic, A., Gredic, M., Pak, O., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057001 · Cited by 63
Self-citationVizza, C. D., Lang, I. M., Badagliacca, R., Benza, R. L., Rosenkranz, S., White, R. J., Adir, Y., Andreassen, A. K., Balasubramanian, V. P., Bartolome, S., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202109-2079pp · Cited by 63
Sox17 Deficiency Promotes Pulmonary Arterial Hypertension via HGF/c-Met Signaling
Park, C. S., Kim, S. H., Yang, H. Y., Kim, J., SCHERMULY, R. T., Cho, Y. S., Kang, H., Park, J., Lee, E., Park, H., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.320845 · Cited by 60
Jandl, K., Marsh, L. M., Hoffmann, J., Mutgan, A. C., Baum, O., Bloch, W., Puthenparampil, H. T., Kolb, D., Sinn, K., Klepetko, W., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0303oc · Cited by 60
Redefining pulmonary hypertension
Maron, B. A., Brittain, E. L., Choudhary, G., & Gladwin, M. T. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30498-8 · Cited by 59
Self-citationDauriat, G., Reynaud‐Gaubert, M., Cottin, V., Lamia, B., Montani, D., Canuet, M., Boissin, C., Tromeur, C., Chaouat, A., Degano, B., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.021 · Cited by 59
JAGGED-NOTCH3 signaling in vascular remodeling in pulmonary arterial hypertension
Zhang, Y., Hernandez, M., Gower, J. R., Winicki, N. M., Morataya, X., Alvarez, S., Yuan, J. X. ‐., Shyy, J., & Thistlethwaite, P. A. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl5471 · Cited by 57
Mural Cell SDF1 Signaling Is Associated with the Pathogenesis of Pulmonary Arterial Hypertension
Yuan, K., Liu, Y., Zhang, Y., Nathan, A., Tian, W., Yu, J. E., Sweatt, A. J., Shamskhou, E. A., Condon, D. F., Chakraborty, A., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0401oc · Cited by 53
Comparison of Human and Experimental Pulmonary Veno-Occlusive Disease
Manaud, G., Nossent, E. J., Lambert, M., Ghigna, M., Boët, A., Vinhas, M.-C., Ranchoux, B., Dumas, S. J., Courboulin, A., Girerd, B., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0015oc · Cited by 52
An emerging phenotype of pulmonary arterial hypertension patients carryingSOX17variants
Montani, D., Lechartier, B., Girerd, B., Eyries, M., Ghigna, M., Savale, L., Jaïs, X., Seferian, A., Jevnikar, M., Boucly, A., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.00656-2022 · Cited by 51
A Mobile Health Intervention to Increase Physical Activity in Pulmonary Arterial Hypertension
Hemnes, A. R., Silverman-Lloyd, L. G., Huang, S., MacKinnon, G. E., Annis, J. S., Whitmore, C. S., Mallugari, R. R., Oggs, R., Hekmat, R., Shan, R., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.04.012 · Cited by 50
Right ventricular pressure-volume loop shape and systolic pressure change in pulmonary hypertension
Richter, M. J., Hsu, S., Yogeswaran, A., Husain‐Syed, F., Vadász, I., Ghofrani, H. A., Naeije, R., Harth, S., Grimminger, F., Seeger, W., et al. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00583.2020 · Cited by 50
Oliveira, R. K. F., Faria‐Urbina, M., Maron, B. A., Santos, M., Waxman, A. B., & Systrom, D. M. (2017) · Pulmonary Circulation · doi:10.1177/2045893217709025 · Cited by 46
Self-citationRats with a Human Mutation of NFU1 Develop Pulmonary Hypertension
Niihori, M., Eccles, C. A., Kurdyukov, S., Zemskova, M., Varghese, M. V., Степанова, А., Galkin, A. S., Rafikov, R., & Rafikova, O. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0065oc · Cited by 45
Fan, Y., Gu, X., Zhang, J., Sinn, K., Klepetko, W., Wu, N., Foris, V., Solymosi, P., Kwapiszewska, G., & Kuebler, W. M. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201909-1884oc · Cited by 45
D’Alto, M., Badagliacca, R., Giudice, F. L., Argiento, P., Casu, G., Corda, M., Correale, M., Ghio, S., Greco, A., Lattanzio, M., et al. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.08.016 · Cited by 44
Curran, L., Nah, G., Marcus, G. M., Tseng, Z. H., Crawford, M. H., & Parikh, N. I. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023663 · Cited by 43
Richter, M. J., Yogeswaran, A., Husain‐Syed, F., Vadász, I., Rako, Z. A., Mohajerani, E., Ghofrani, H. A., Naeije, R., Seeger, W., Herberg, U., et al. (2021) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeab038 · Cited by 43
Ferreira, J. P., Cleland, J. G. F., Girerd, N., Bozec, E., Rossignol, P., Pellicori, P., Cosmi, F., Mariottoni, B., Solomon, S. D., Pitt, B., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2726 · Cited by 42
Blette, B. S., Moutchia, J., Al‐Naamani, N., Ventetuolo, C. E., Cheng, C., Appleby, D. H., Urbanowicz, R. J., Fritz, J. S., Mazurek, J. A., Li, F., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00155-8 · Cited by 39
Self-citationObesity in Pulmonary Arterial Hypertension. The Pulmonary Hypertension Association Registry
Min, J., Feng, R., Badesch, D., Rosenzweig, E. B., Burger, C., Chakinala, M. M., Marco, T. D., Feldman, J., Hemnes, A. R., Horn, E. M., et al. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202006-612oc · Cited by 38
Self-citationOxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension
Howden, E. J., Carmona, S. R., Claeys, M., Bosscher, R. D., Willems, R., Meyns, B. P., Verbelen, T., Maleux, G. A., Godinas, L., Belge, C., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.052899 · Cited by 37
Brittain, E. L., Thenappan, T., Huston, J., Agrawal, V., Lai, Y., Dixon, D., Ryan, J. J., Lewis, E. F., Redfield, M. M., Shah, S. J., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001079 · Cited by 36
Self-citationTu, L., Thuillet, R., Perrot, J., Ottaviani, M., Ponsardin, E., Kolkhof, P., Humbert, M. J. C., Viengchareun, S., Lombès, M., & Guignabert, C. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19207 · Cited by 36
Shen, Y., Goncharov, D. A., Pena, A. Z., Baust, J., Barragan, A. C., Ray, A., Rode, A., Bachman, T. N., Chang, B., Jiang, L., et al. (2022) · Science Signaling · doi:10.1126/scisignal.abn2743 · Cited by 36
Vitry, G., Paulin, R., Grobs, Y., Lampron, M.-C., Shimauchi, T., Lemay, S.-E. S., Tremblay, È., Habbout, K., Awada, C., Bourgeois, A., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0627oc · Cited by 36
Macías, D., Moore, S., Crosby, A., Southwood, M. R., Du, X., Tan, H., Xie, S., Vassallo, A. M., Wood, A. J. T., Wallace, E. M., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02061-2019 · Cited by 35
Koudstaal, T., van Hulst, J. A. C., Das, T., Neys, S. F. H., Merkus, D., Bergen, I. M., de Raaf, M. A., Bogaard, H. J., Boon, L., Loo, G., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0443oc · Cited by 35
Bernardo, R. J., Lu, D., Ramírez, R. L., Hedlin, H., Kawut, S. M., Bull, T., Marco, T. D., Ford, H. J., Grinnan, D., Klinger, J. R., et al. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202109-1051oc · Cited by 34
Huang, J., Lu, W., Ouyang, H., Chen, Y., Zhang, C., Luo, X., Li, M., Shu, J., Zheng, Q., Chen, H., et al. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0165oc · Cited by 33
Risk assessment in pulmonary hypertension based on routinely measured laboratory parameters
Yogeswaran, A., Tello, K., Lund, J., Klose, H. F. E., Harbaum, L., Sommer, N., Oqueka, T., Hennigs, J. K., Grimminger, F., Seeger, W., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.10.018 · Cited by 33
Self-citationBadagliacca, R., Rischard, F. P., Giudice, F. L., Howard, L., Papa, S., Valli, G., Manzi, G., Sciomer, S., Palange, P., Garcia, J. G. N., et al. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.02.021 · Cited by 32
Alba, G. A., Samokhin, A. O., Wang, R., Zhang, Y., Wertheim, B. M., Arons, E., Greenfield, E. A., Slingsby, M. H. L., Ceglowski, J. R., Haley, K. J., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0719oc · Cited by 32
Self-citationWertheim, B. M., Wang, R., Guillermier, C., Hütter, C. V. R., Oldham, W. M., Menche, J., Steinhauser, M. L., & Maron, B. A. (2023) · JCI Insight · doi:10.1172/jci.insight.163932 · Cited by 30
Self-citationBenza, R. L., Gomberg‐Maitland, M., Farber, H. W., Vizza, C. D., Broderick, M. J., Holdstock, L., Nelsen, A. C., Deng, C., Rao, Y., & White, R. J. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.08.006 · Cited by 30
A Novel Protective Role for Matrix Metalloproteinase-8 in the Pulmonary Vasculature
Dieffenbach, P. B., Haeger, C. M., Rehman, R., Corcoran, A. M., Coronata, A. M. F., Vellarikkal, S. K., Chrobak, I., Waxman, A. B., Vitali, S. H., Sholl, L. M., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202108-1863oc · Cited by 30
Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1
Jutant, E., Jaïs, X., Girerd, B., Savale, L., Ghigna, M., Perros, F., Mignard, X., Jevnikar, M., Bourlier, D., Prévôt, G., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202001-0105oc · Cited by 30
Finding Pulmonary Arterial Hypertension—Switching to Offense to Mitigate Disease Burden
Maron, B. A., & Humbert, M. J. C. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.0011 · Cited by 29
Self-citationHansmann, G., Chouvarine, P., Diekmann, F., Giera, M. A., Ralser, M., Mülleder, M., von Kaisenberg, C., Bertram, H., Legchenko, E., & Hass, R. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00083-z · Cited by 28
Maron, B. A., Kleiner, D. E., Arons, E., Wertheim, B. M., Sharma, N., Haley, K. J., Samokhin, A. O., Rowin, E. J., Maron, M. S., Rosing, D. R., et al. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.09.040 · Cited by 28
Self-citationIncreased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension
Sun, X., Peters, E. L., Schalij, I., Axelsen, J. B., Andersen, S., Kurakula, K., Gomez‐Puerto, M. C., Szulcek, R., Pan, X., Bós, D. D. S. G., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0105oc · Cited by 26
Minhas, J., Shou, H., Hershman, S. G., Zamanian, R. T., Ventetuolo, C. E., Bull, T. M., Hemnes, A. R., Chakinala, M. M., Mathai, S. C., Al‐Naamani, N., et al. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202105-560oc · Cited by 25
Self-citationUrban–Rural Disparities in Pulmonary Hypertension Mortality
Macías, C. G., Wharam, J. F., Maron, B. A., & Ong, M. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202003-234rl · Cited by 23
Self-citationMin, J., Badesch, D. B., Chakinala, M. M., Elwing, J., Frantz, R. P., Horn, E. M., Klinger, J. R., Lammi, M. R., Mazimba, S., Sager, J. S., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202010-3967le · Cited by 23
Self-citationPulmonary arterial hypertension with below threshold pulmonary vascular resistance
Ratwatte, S., Anderson, J., Strange, G. A., Corrigan, C., Collins, N. J., Celermajer, D. S., Dwyer, N., Feenstra, J., Keating, D., Kotlyar, E., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01654-2019 · Cited by 23
Unmasking right ventricular-arterial uncoupling during fluid challenge in pulmonary hypertension
Kremer, N., Rako, Z. A., Douschan, P., Gall, H. J., Ghofrani, H. A., Grimminger, F., Guth, S., Naeije, R., Rieth, A. J., Schulz, R., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.11.019 · Cited by 23
Liu, W., Zhang, Y., Lu, L., Wang, L., Chen, M., & Hu, T. (2017) · Medical Science Monitor · doi:10.12659/msm.900354 · Cited by 21
Inhaled Iloprost Improves Right Ventricular Load–Independent Contractility in Pulmonary Hypertension
Tello, K., Kremer, N., Richter, M. J., Gall, H. J., Münks, J., Ghofrani, H. A., SCHERMULY, R. T., Naeije, R., Kojonazarov, B. K., & Seeger, W. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202201-0095le · Cited by 21
Quatredeniers, M., Nakhleh, M. K., Dumas, S. J., Courboulin, A., Vinhas, M. C., Antigny, F., Phan, C., Guignabert, C., Bendifallah, I., Vocelle, M., et al. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00537.2017 · Cited by 20
Sakamoto, Y., Kameshima, S., Kakuda, C., Okamura, Y., Kodama, T., Okada, M., & Yamawaki, H. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-2043-6 · Cited by 18
Zhang, Y., Zervopoulos, S. D., Boukouris, A. E., Carrillo, M. A. L., Saleme, B., Webster, L., Liu, Y., Haromy, A., Dakhili, S. A. T., Ussher, J. R., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020451 · Cited by 17
Risk, Results, and Costs: Optimizing Clinical Trial Efficiency through Prognostic Enrichment
Viele, K., & Girard, T. D. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3649ed · Cited by 17
Methamphetamine-associated pulmonary arterial hypertension
Kolaitis, N. A., Saggar, R., & Marco, T. D. (2022) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000888 · Cited by 16
CASCINO, T. M., & McLaughlin, V. V. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202107-1625ed · Cited by 16
Al‐Naamani, N., Pan, H., Anderson, M. R., Torigian, D. A., Tong, Y., Oyster, M. L., Porteous, M. K., Palmer, S. M., Arcasoy, S. M., Diamond, J. M., et al. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202003-247oc · Cited by 15
Inhibiting Jak2 Ameliorates Pulmonary Hypertension: Fulfilling the Promise of Precision Medicine
Leopold, J. A. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0384ed · Cited by 13
Inhalation of Stachybotrys chartarum Fragments Induces Pulmonary Arterial Remodeling
Croston, T. L., Lemons, A. R., Barnes, M. A., Goldsmith, W. T., Orandle, M. S., Nayak, A. P., Germolec, D. R., Green, B. J., & Beezhold, D. H. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0221oc · Cited by 12
Repeatability of Pulmonary Pressure Measurements in Patients with Pulmonary Hypertension
Melillo, C. A., Lane, J. E., Aulak, K. S., Almoushref, A., Dweik, R. A., & Tonelli, A. R. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202002-182rl · Cited by 12
Johnson, S. W., Finlay, L., Mathai, S. C., Goldstein, R. H., & Maron, B. A. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12126 · Cited by 12
Self-citationInhibition of immunoglobulin E attenuates pulmonary hypertension
Shu, T., Liu, Y., Zhou, Y., Zhou, Z., Li, B., Xing, Y., Yang, P. B., Pang, J., Li, J., Song, X., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00095-9 · Cited by 11
Schoenberg, N. C., & Farber, H. W. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202008-3313ed · Cited by 11
Farmakis, I. T., Vazakidis, P., Doundoulakis, I., Arvanitaki, A., Zafeiropoulos, S., Boutou, A., Karvounis, H. I., & Giannakoulas, G. A. (2021) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2021.102036 · Cited by 10
Pulmonary hypertension thresholds: time to lower further?
Provencher, S., Boucherat, O., Potus, F., & Bonnet, S. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30326-x · Cited by 4
Metadata
- Authors
- Johnson, S., Sommer, N., Cox-Flaherty, K., Weissmann, N., Ventetuolo, C. E., & Maron, B. A.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-09-01
- Volume
- 208
- Issue
- 5
- Pages
- 528-548
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W4384282523
- Cited by
- 190
- References
- 158
- FWCI
- 30.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.